In the laboratory, american Fruits, recently announced an evolution in the study against the COVID-19, revealing it had found an Antibody that provides the 100% inhibition against the infection caused by SARS-CoV-2 in Healthy Cells after four days of incubation.

The research, however, has not yet been carried out on humans, if it’s just for a study, pre-clinical in-vitro. The lab believes the development of such a vaccine is promising, and continues to work on the production of a cocktail of antibodies, to protect the people of the new coronavirus, even as it passes through changes.

The name of the STI-1499, the antibody was first discovered by the Sorrento was the highlight in the middle at the expense of the applicants that seek to block the interaction of a protein is challenging for the SARS-CoV-2 to the inside of the body. Once locked on, the new coronavirus does not connect with the healthy cells of the host. Being Effective on the STI-1499 is to be the first antibody was confirmed at the cocktail party, which is currently being developed.

One of the main focal points of the studies of the researchers is to be able to respond to how the mutagen is, for the SARS-CoV-2, whereas other types of coronaviruses have a tendency to mutate rapidly, which makes it difficult to develop cures and effective treatments.

The Fruits, said to be already in talks with regulatory bodies to facilitate the development of the treatment, as well as to increase the production capacity, in the case of the final tests will be positive, and then produces up to a million times in a single turn.